- Home
- MYND vs RFL Comparison
MYND vs RFL Comparison
Compare MYND & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYND
- RFL
- Stock Information
- Founded
- MYND 1998
- RFL 2017
- Country
- MYND Cayman Islands
- RFL United States
- Employees
- MYND N/A
- RFL N/A
- Industry
- MYND Other Consumer Services
- RFL Real Estate
- Sector
- MYND Real Estate
- RFL Finance
- Exchange
- MYND Nasdaq
- RFL Nasdaq
- Market Cap
- MYND 31.7M
- RFL 48.4M
- IPO Year
- MYND 2017
- RFL N/A
- Fundamental
- Price
- MYND $1.35
- RFL $2.40
- Analyst Decision
- MYND
- RFL
- Analyst Count
- MYND 0
- RFL 0
- Target Price
- MYND N/A
- RFL N/A
- AVG Volume (30 Days)
- MYND 247.3K
- RFL 54.6K
- Earning Date
- MYND 11-03-2024
- RFL 10-28-2024
- Dividend Yield
- MYND N/A
- RFL N/A
- EPS Growth
- MYND N/A
- RFL N/A
- EPS
- MYND N/A
- RFL N/A
- Revenue
- MYND $357,050,000.00
- RFL $540,000.00
- Revenue This Year
- MYND N/A
- RFL N/A
- Revenue Next Year
- MYND N/A
- RFL N/A
- P/E Ratio
- MYND N/A
- RFL N/A
- Revenue Growth
- MYND N/A
- RFL 92.86
- 52 Week Low
- MYND $0.61
- RFL $1.29
- 52 Week High
- MYND $14.20
- RFL $2.44
- Technical
- Relative Strength Index (RSI)
- MYND 59.16
- RFL 87.25
- Support Level
- MYND $0.61
- RFL $2.00
- Resistance Level
- MYND $1.80
- RFL $1.94
- Average True Range (ATR)
- MYND 0.19
- RFL 0.10
- MACD
- MYND 0.10
- RFL 0.03
- Stochastic Oscillator
- MYND 62.15
- RFL 94.85
About MYND Mynd.ai Inc.
Mynd.ai Inc is a company that provides a platform for delivering digital content in K-12 classrooms, giving teachers seamless connectivity to inspire young minds. It features agnostic hardware that integrates across technology providers. Its product line includes a wide range of interactive tools and technologies, with its award-winning interactive displays at the forefront. It also offers interactive software apps such as Screen Share, computing modules, and accessories that meet the needs of customers, including K -12 educators, colleges and universities, small businesses and corporations, government agencies, and more.
About RFL Rafael Holdings Inc. Class B
Rafael Holdings Inc, through its subsidiaries, is a clinical stage, oncology-focused pharmaceutical company committed to the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. The company is a significant investor in two clinical stage oncology companies, Cornerstone Pharmaceuticals, Inc., and LipoMedix Pharmaceuticals Ltd.